Suchergebnisse - "Minomo, Shojiro"

PubPharm (37)

1

Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

enthalten in: Journal of clinical medicine | 2023

von Arai, T. | Takimoto, T. | Takeuchi, N. | +3

2

Concomitant Recurrent Pneumothorax and Takotsubo Cardiomyopathy in a Chronic Obstructive Pulmonary Disease Patient

enthalten in: Cureus | 2022

von Takimoto, T. | Kobayashi, T. | Minomo, S.

3

Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion

enthalten in: Investigational new drugs | 2021

von Tamiya, M. | Tamiya, A. | Suzuki, H. | +14

4

Risk factors for hemoptysis in Mycobacterium avium complex lung disease

enthalten in: Respiratory investigation | 2021

von Minomo, S. | Kobayashi, T. | Katayama, K. | +5

5

Resumption/efficacy and safety of an azithromycin-containing regimen against Mycobacterium avium complex lung disease in patients who experienced adverse effects with a clarithromycin-containing regimen

enthalten in: Respiratory investigation | 2021

von Kobayashi, T. | Tsuyuguchi, K. | Yoshida, S. | +6

6

B cell-activating factors in autoimmune pulmonary alveolar proteinosis

enthalten in: Orphanet journal of rare diseases | 2021

von Hirose, M. | Arai, T. | Sugimoto, C. | +11

7

B cell‐activating factors in autoimmune pulmonary alveolar proteinosis

enthalten in: Orphanet journal of rare diseases | 2021

von Hirose, M. | Arai, T. | Sugimoto, C. | +11

8

Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion

enthalten in: Investigational new drugs | 2021

von Tamiya, M. | Tamiya, A. | Suzuki, H. | +14

9

Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion

enthalten in: Investigational new drugs | 2021

von Tamiya, M. | Tamiya, A. | Suzuki, H. | +14

10

Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion

enthalten in: Investigational new drugs | 2021

von Tamiya, M. | Tamiya, A. | Suzuki, H. | +14